SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gg cox who wrote (13672)10/4/2004 10:40:43 AM
From: Chip   of 14101
 
Although the reason Vioxx caused heart problems is not certain, researchers believe its selective action on the COX-2 enzyme, but not the COX-1, throws the prostanoids involved in clotting out of balance.

The result is a tendency for blood to clot -- and clots are the first step of heart attacks and most strokes. If that theory is correct, it means that Vioxx's cleverness was also its Achilles' heel.


How would Vioxx be any different then Celebrex. Since they're both COX-2 drugs, is it possible Celebrex might also be pulled off the market sometime in the future?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext